Patents, access, and local production of medicines
Reflections from experiences in the SUS
Datos Bibliográficos
| ID | 3074403 |
|---|---|
| Autores | Daniela Rangel Affonso Fernandes (0000-0002-0969-2707, Fundação Oswaldo Cruz), Carlos Augusto Grabois Gadelha (0000-0002-9148-8819, Fundação Oswaldo Cruz), Jose Manuel Santos De Varge Maldonado (0000-0002-0815-1765, Fundação Oswaldo Cruz) |
| Año | 2024 |
| Volumen | 33 |
| Número | 1 |
| Fecha de publicación | 2024-01-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Saúde e Sociedade (JOURNAL) |
| Identificadores de la revista | ISSN: 0104-1290 • E-ISSN: 1984-0470 |
| Editorial | FapUNIFESP (SciELO) (PUBLISHER) |
| DOI | 10.1590/s0104-12902024220791en |
| OpenAlex | W4392867243 |
| Idioma | EN |
| Citas recibidas | 2 |
| Referencias citadas | 18 |
This article aims to contribute to the literature and to the national and global debate on overcoming the polarization related to the legal and administrative aspect of the innovation process, seeking to focus on patents as a conditioning factor of the technological trajectories that enable learning in the productive scope. It was based on a theoretical and political framework related to innovation and access to medicines, especially regarding Intellectual Property rights, and on a critical-reflexive analysis of Intellectual Property instruments used in Productive Development Partnerships (PDP), developed by a public national institute for synthetic drug technology. The results demonstrate the importance of making patent rights compatible with the construction of technological and innovation capacities in the country, which are linked to universal access, especially when they involve products that are intended to treat serious, technologically complex and high-cost diseases. In conclusion, to overcome technological dependence and expand access to medicines in Brazil, the State must seek a balance between public and private interests in the healthcare area, articulate the existing legal instruments and align its health, industry, ST&I and intellectual property policies
Access to medicines · Balance (ability) · Bridging (networking) · Business · Economics · Intellectual property · Law and economics · Political science · Politics · Production (economics) · Reflexivity · Scope (computer science) · Sociology · State (computer science) · Biotechnology and Related Fields · Intellectual Property and Patents · Law · Medicine · Pharmaceutical Economics and Policy
Perspective—Tacit Knowledge and Knowledge Conversion
Estratégia de proteção de patentes farmacêuticas
Licença compulsória do efavirenz no Brasil em 2007
O complexo industrial da saúde e a necessidade de um enfoque dinâmico na economia da saúde
Desenvolvimento, Inovação e Saúde
Sistemas de inovação e desenvolvimento
Acesso a medicamentos e propriedade intelectual no Brasil
Pesquisa translacional e sistemas de inovação na saúde
O papel dos produtores públicos de medicamentos e ações estratégicas na pandemia da Covid-19
Estratégias de inovação em medicamentos e vacinas no âmbito do Ceis - modelos, mecanismos e expectativas
A evolução do sistema internacional de propriedade intelectual
O custo da extensão da vigência de patentes de medicamentos para o Sistema Único de Saúde
Ativismo, políticas públicas e acesso a medicamentos
| Obras citantes distintas | 2 |
|---|---|
| Citas por año | 2 |
| Intervalo de citas | 2025 - 2026 (2) |
| Velocidad de citación | current |
| Altamente citado | No |
| Tipos de cita | Neutras: 2 |